Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03385369” into the
“Other Terms” search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D5670C00012” into the search box, and click “Find a Study”.
Full study title: A Phase 1, Randomized, Blinded, Single Ascending Dose Study
to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Overweight/Obese
Subjects of Japanese or Chinese Descent
National Clinical Trials number: NCT03385369
AstraZeneca Protocol Number: D5670C00012
MedImmune Ltd., an AstraZeneca company, sponsored this study and has its
headquarters in Gaithersburg, United States.
The phone number for the AstraZeneca Information Center is +1 877 240 9479.
Thank you!
Clinical trial participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for participants.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization
focused on educating and informing the public about
clinical research participation. CISCRP is not involved
in recruiting patients for clinical studies, nor is it
involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100
Boston, MA 02109
1-877-MED-HERO
8
Version 2.1 2019_06_19